Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.4.1. Impact Of Covid-19 On 3D Bioprinting Market
2.5. Major Market Findings
2.5.1. Emergence Of 4D Bioprinting As A Substitute For 3D Bioprinting
2.5.2. Personalized Medicine Likely To Boost 3D Bioprinting
2.5.3. Rising Interest In The Application Of Bioprinting Against The Sars-Cov-2 Virus

3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Geriatric Population
3.1.2. Technological Advancements And R&D Investments
3.1.3. Rising Focus On Regenerative Medicine
3.1.4. High Prevalence Of Chronic Conditions
3.2. Key Restraints
3.2.1. Operational Challenges During Manufacturing
3.2.2. Exorbitant Costs Of 3D Bioprinters
3.2.3. Lack Of Trained Professionals

4. Key Analytics
4.1. Parent Market Analysis
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping
4.4.1. Growth Prospect Mapping In Germany
4.5. Market Maturity Analysis
4.6. Market Concentration Analysis
4.7. Value Chain Analysis
4.7.1. Design & Software Providers
4.7.2. Prototype Production
4.7.3. Distribution
4.7.4. End-Users

5. Market By Component
5.1. 3D Bioprinter
5.2. Bioink

6. Market By Biomaterial
6.1. Hydrogel
6.2. Living Cells
6.3. Extracellular Matrices
6.4. Other Biomaterials

7. Market By Technology
7.1. Magnetic Levitation Bioprinting
7.2. Inkjet-Based Bioprinting
7.3. Syringe/Extrusion-Based Bioprinting
7.4. Laser-Assisted Bioprinting
7.5. Other Technologies

8. Market By Application
8.1. Drug Testing & Development
8.2. Tissue Engineering & Regenerative Medicine
8.3. Food Testing
8.4. Research
8.5. Other Applications

9. Market By End-User
9.1. Hospitals
9.2. Biopharmaceuticals Companies
9.3. Research Organizations And Academic Institutes
9.4. Other End-Users

10. Geographical Analysis
10.1. Europe
10.1.1. Market Size & Estimates
10.1.2. Europe 3D Bioprinting Market Drivers
10.1.3. Europe 3D Bioprinting Market Challenges
10.1.4. Europe 3D Bioprinting Market Regulatory Framework
10.1.5. Key Players In Europe 3D Bioprinting Market
10.1.6. Country Analysis
10.1.6.1. United Kingdom
10.1.6.1.1. United Kingdom 3D Bioprinting Market Size & Opportunities
10.1.6.2. Germany
10.1.6.2.1. Germany 3D Bioprinting Market Size & Opportunities
10.1.6.3. France
10.1.6.3.1. France 3D Bioprinting Market Size & Opportunities
10.1.6.4. Italy
10.1.6.4.1. Italy 3D Bioprinting Market Size & Opportunities
10.1.6.5. Spain
10.1.6.5.1. Spain 3D Bioprinting Market Size & Opportunities
10.1.6.6. Nordic Countries
10.1.6.6.1. Nordic Countries 3D Bioprinting Market Size & Opportunities
10.1.6.7. Rest Of Europe
10.1.6.7.1. Rest Of Europe 3D Bioprinting Market Size & Opportunities

11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Mergers & Acquisitions
11.1.2. Product Launches & Developments
11.1.3. Partnerships & Agreements
11.2. Company Profiles
11.2.1. 3D Bioprinting Solutions
11.2.1.1. Company Overview
11.2.1.2. Products List
11.2.2. Advanced Solutions Life Sciences
11.2.2.1. Company Overview
11.2.2.2. Products List
11.2.3. Allevi
11.2.3.1. Company Overview
11.2.3.2. Products List
11.2.4. Cellink
11.2.4.1. Company Overview
11.2.4.2. Products List
11.2.4.3. Strengths & Challenges
11.2.5. Collplant Biotechnologies Ltd
11.2.5.1. Company Overview
11.2.5.2. Products List
11.2.6. Cyfuse Biomedical Kk
11.2.6.1. Company Overview
11.2.6.2. Products List
11.2.6.3. Strengths & Challenges
11.2.7. Envisiontec ? Inc
11.2.7.1. Company Overview
11.2.7.2. Products List
11.2.7.3. Strengths & Challenges
11.2.8. Gesim Gmbh
11.2.8.1. Company Overview
11.2.8.2. Products List
11.2.8.3. Strengths & Challenges
11.2.9. Inventia Life Science Pty Ltd
11.2.9.1. Company Overview
11.2.9.2. Products List
11.2.10. Organovo Holdings Inc
11.2.10.1. Company Overview
11.2.10.2. Products List
11.2.10.3. Strengths & Challenges
11.2.11. Regemat 3D
11.2.11.1. Company Overview
11.2.11.2. Products List
11.2.11.3. Strengths & Challenges
11.2.12. Regenhu
11.2.12.1. Company Overview
11.2.12.2. Products List
11.2.12.3. Strengths & Challenges
11.2.13. Revotek Co Ltd
11.2.13.1. Company Overview
11.2.13.2. Products List
11.2.14. Rokit Healthcare Inc
11.2.14.1. Company Overview
11.2.14.2. Products List
11.2.15. Stratasys Ltd
11.2.15.1. Company Overview
11.2.15.2. Products List



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Growth Prospect Mapping For Germany
Figure 4: Market Maturity Analysis
Figure 5: Market Concentration Analysis
Figure 6: Value Chain Analysis
Figure 7: Europe 3D Bioprinting Market, Growth Potential, By Component, In 2022
Figure 8: Europe 3D Bioprinting Market, By 3D Bioprinter, 2023-2032 (In $ Million)
Figure 9: Europe 3D Bioprinting Market, By Bioink, 2023-2032 (In $ Million)
Figure 10: Europe 3D Bioprinting Market, Growth Potential, By Biomaterial, In 2022
Figure 11: Europe 3D Bioprinting Market, By Hydrogel, 2023-2032 (In $ Million)
Figure 12: Europe 3D Bioprinting Market, By Living Cells, 2023-2032 (In $ Million)
Figure 13: Europe 3D Bioprinting Market, By Extracellular Matrices, 2023-2032 (In $ Million)
Figure 14: Europe 3D Bioprinting Market, By Other Biomaterials, 2023-2032 (In $ Million)
Figure 15: Europe 3D Bioprinting Market, Growth Potential, By Technology, In 2022
Figure 16: Europe 3D Bioprinting Market, By Magnetic Levitation Bioprinting, 2023-2032 (In $ Million)
Figure 17: Europe 3D Bioprinting Market, By Inkjet-Based Bioprinting, 2023-2032 (In $ Million)
Figure 18: Europe 3D Bioprinting Market, By Syringe/Extrusion-Based Bioprinting, 2023-2032 (In $ Million)
Figure 19: Europe 3D Bioprinting Market, By Laser-Assisted Bioprinting, 2023-2032 (In $ Million)
Figure 20: Europe 3D Bioprinting Market, By Other Technologies, 2023-2032 (In $ Million)
Figure 21: Europe 3D Bioprinting Market, Growth Potential, By Application, In 2022
Figure 22: Europe 3D Bioprinting Market, By Drug Testing & Development, 2023-2032 (In $ Million)
Figure 23: Europe 3D Bioprinting Market, By Tissue Engineering & Regenerative Medicine, 2023-2032 (In $ Million)
Figure 24: Europe 3D Bioprinting Market, By Food Testing, 2023-2032 (In $ Million)
Figure 25: Europe 3D Bioprinting Market, By Research, 2023-2032 (In $ Million)
Figure 26: Europe 3D Bioprinting Market, By Other Applications, 2023-2032 (In $ Million)
Figure 27: Europe 3D Bioprinting Market, Growth Potential, By End-User, In 2022
Figure 28: Europe 3D Bioprinting Market, By Hospitals, 2023-2032 (In $ Million)
Figure 29: Europe 3D Bioprinting Market, By Biopharmaceuticals Companies, 2023-2032 (In $ Million)
Figure 30: Europe 3D Bioprinting Market, By Research Organizations And Academic Institutes, 2023-2032 (In $ Million)
Figure 31: Europe 3D Bioprinting Market, By Other End-Users, 2023-2032 (In $ Million)
Figure 32: Europe 3D Bioprinting Market, Country Outlook, 2022 & 2032 (In %)
Figure 33: United Kingdom 3D Bioprinting Market, 2023-2032 (In $ Million)
Figure 34: Germany 3D Bioprinting Market, 2023-2032 (In $ Million)
Figure 35: France 3D Bioprinting Market, 2023-2032 (In $ Million)
Figure 36: Italy 3D Bioprinting Market, 2023-2032 (In $ Million)
Figure 37: Spain 3D Bioprinting Market, 2023-2032 (In $ Million)
Figure 38: Nordic Countries 3D Bioprinting Market, 2023-2032 (In $ Million)
Figure 39: Rest Of Europe 3D Bioprinting Market, 2023-2032 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – 3D BIOPRINTING
TABLE 2: COMPARATIVE SUMMARY OF 3D BIOPRINTING TECHNOLOGIES
TABLE 3: LIST OF APPROVED TISSUE-ENGINEERED MEDICAL PRODUCTS (TEMPS) USED IN VARIOUS COUNTRIES
TABLE 4: EUROPE 3D BIOPRINTING MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: EUROPE 3D BIOPRINTING MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: EUROPE 3D BIOPRINTING MARKET, BY BIOMATERIAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: EUROPE 3D BIOPRINTING MARKET, BY BIOMATERIAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: EUROPE 3D BIOPRINTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: EUROPE 3D BIOPRINTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: EUROPE 3D BIOPRINTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: EUROPE 3D BIOPRINTING MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: EUROPE 3D BIOPRINTING MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: EUROPE 3D BIOPRINTING MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: EUROPE 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
TABLE 17: KEY PLAYERS OPERATING IN EUROPE 3D BIOPRINTING MARKET
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS